Brooks Laboratories Limited Statistics
Want to see IN:BROOKS full AI Analyst Report?
Brooks Laboratories Limited (BROOKS) Stock Statistics & Valuation Metrics
Total Valuation
Brooks Laboratories Limited has a market cap or net worth of INR 2.06B. The enterprise value is INR 1.05B.
- Market Cap
- INR 2.06B
- Enterprise Value
- INR 1.05B
Share Statistics
Brooks Laboratories Limited has 29,457,249 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 29,457,249
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Brooks Laboratories Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 4.12%.
- Return on Equity (ROE)
- 0.20
- Return on Assets (ROA)
- 0.17
- Return on Invested Capital (ROIC)
- 4.12%
- Return on Capital Employed (ROCE)
- 0.04
- Revenue Per Employee
- 2.47M
- Profits Per Employee
- 708.46K
- Employee Count
- 347
- Asset Turnover
- 0.58
- Inventory Turnover
- 6.15
Valuation Ratios
The current PE Ratio of Brooks Laboratories Limited is 2.83. Brooks Laboratories Limited’s PEG ratio is 0.01.
- PE Ratio
- 2.83
- PS Ratio
- 2.61
- PB Ratio
- 1.09
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Brooks Laboratories Limited had revenue of 857.38M and earned 245.84M in profits. Earnings per share was 8.35.
- Revenue
- 857.38M
- Gross Profit
- 179.65M
- Operating Income
- 54.70M
- Pretax Income
- 245.84M
- Net Income
- 245.84M
- EBITDA
- 270.09M
- Earnings Per Share (EPS)
- 8.35
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Brooks Laboratories Limited pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 35.38%
Stock Price Statistics
- Beta
- 1.56
- 52-Week Price Change
- -34.67%
- 50-Day Moving Average
- 62.78
- 200-Day Moving Average
- 63.25
- Relative Strength Index (RSI)
- 59.91
- Average Volume (3m)
- 12.86K
Important Dates
Brooks Laboratories Limited upcoming earnings date is Feb 17, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 07, 2026
- Next Earnings Date
- Feb 17, 2027
- Ex-Dividend Date
- ―
Financial Position
Brooks Laboratories Limited as a current ratio of 1.72, with Debt / Equity ratio of 6.94%
- Current Ratio
- 1.72
- Quick Ratio
- 1.21
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- 0.04
- Interest Coverage Ratio
- 6.55
Taxes
In the past 12 months, Brooks Laboratories Limited has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Brooks Laboratories Limited EV to EBITDA ratio is 29.26, with an EV/FCF ratio of 0.00.
- EV to Sales
- 1.88
- EV to EBITDA
- 29.26
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Brooks Laboratories Limited has INR 654.25M in cash and marketable securities with INR 70.97M in debt, giving a net cash position of INR 583.28M billion.
- Cash & Marketable Securities
- INR 654.25M
- Total Debt
- INR 70.97M
- Net Cash
- INR 583.28M
- Net Cash Per Share
- INR 19.80
- Tangible Book Value Per Share
- INR 63.98
Margins
Gross margin is 20.34%, with operating margin of 2.44%, and net profit margin of 92.23%.
- Gross Margin
- 20.34%
- Operating Margin
- 2.44%
- Pretax Margin
- 98.96%
- Net Profit Margin
- 92.23%
- EBITDA Margin
- 6.41%
- EBIT Margin
- 4.30%
Analyst Forecast
The average price target for Brooks Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -14.88%
- EPS Growth Forecast
- 431.30%
Scores
- Smart Score
- ―
- AI Score
- 63

